C12N 2750/14161
Methods of inactivation or attenuation
C12N2750/14161 (Methods of inactivation or attenuation) appears on 38 US grants and 58 published applications in this corpus.
Search patents in C12N- Granted patents
- 38
- Published applications
- 58
- Assignees
- 19
- Inventors
- 56
- Latest grant
- 26 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 4 |
| 2003 | 0 | 2 |
| 2004 | 1 | 2 |
| 2005 | 0 | 0 |
| 2006 | 2 | 4 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 3 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 2 | 2 |
| 2017 | 2 | 4 |
| 2018 | 2 | 4 |
| 2019 | 3 | 7 |
| 2020 | 4 | 3 |
| 2021 | 4 | 3 |
| 2022 | 2 | 5 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Restrictive inverted terminal repeats for viral vectors26 Mar 2024US 11,939,597 B2The University of North Carolina at Chapel Hill
- Restrictive inverted terminal repeats for viral vectors3 Jan 2023US 11,542,478 B2The University of North Carolina at Chapel Hill
- Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby15 Nov 2022US 11,499,167 B2The Trustees of the University of Pennsylvania
- Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby5 Jul 2022US 11,377,669 B2The Trustees of the University of Pennsylvania
- AAV virions with decreased immunoreactivity and uses therefor10 Aug 2021US 11,083,800 B2Genzyme Corporation
- Polynucleotides for use in AAV production30 Apr 2026US 2026/0117201 A1Encoded Therapeutics, Inc.
- Membrane rupture compositions and methods of making and using same19 Jun 2025US 2025/0197794 A1Avantor Performance Materials, Inc.
- Modulators of adeno-associated virus transduction and uses thereof2 Jan 2025US 2025/0001013 A1Novartis AG
- Cns targeting aav vectors and methods of use thereof19 Oct 2023US 2023/0332179 A1University of Massachusetts
- Restrictive inverted terminal repeats for viral vectors1 Jun 2023US 2023/0167418 A1The University of North Carolina at Chapel Hill
Most cited
By later US patents
- Method for detecting adeno-associated virus165US 8,524,446 B2The Trustees of the University of Pennsylvania · 2013
- High efficiency helper system for AAV vector production127US 5,622,856 AAvigen, Inc. · 1997
- Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids95US 7,056,502 B2The Trustees of the University of Pennsylvania · 2006
- High-efficiency wild-type-free AAV helper functions91US 6,001,650 AAvigen, Inc. · 1999
- CNS targeting AAV vectors and methods of use thereof91US 9,102,949 B2University of Massachusetts · 2015